Imagion Biosystems Limited (ASX:IBX)


right-arrow Created with Sketch. -0.003 (-3.66%)
MCAP $88.56M
Last trade 16.10pm 03/12/2021 20mins delayed

Latest Announcements

02/12/2021IBXImagion Biosystems Limited
02/12/2021IBXImagion Biosystems Limited
02/12/2021IBXImagion Biosystems Limited
26/11/2021IBXImagion Biosystems Limited
26/11/2021IBXImagion Biosystems Limited
25/11/2021IBXImagion Biosystems Limited
23/11/2021IBXImagion Biosystems Limited
19/11/2021IBXImagion Biosystems Limited

Company Overview

Imagion Biosystems Limited is an Australia-based healthcare company. The Company's principal activities include nanotechnology, biotechnology, cancer diagnostics and medical imaging using superparamagnetic relaxometry. Its MagSense technology is a functional imaging method for detecting cancers and other critical diseases. MagSense instrument uses sensitive magnetic sensors to detect the tiny bio-safe nanoparticles. MagSense nanoparticles bound to cancer cells act like a magnetic beacon to identify the presence of a tumour. MagSense nanoparticles are supplied as an injectable solution and formulated to provide delivery to specific types of cancer cells. Its PrecisionMRX nanoparticles are developed for magnetic relaxometry and other biomedical applications. It serves a range of applications, including detecting cancer, monitoring therapy and detecting other diseases. Its MagSense HER2 imaging agent is under phase I clinical study.

IBX in the news

Imagion Biosystems (IBX) has received $2.6 million in tax incentives The money…
Imagion Biosystems (IBX) shares are trading in the green as the company…
Imagion Biosystems (IBX) has received $50,000 from the Federal Government for its…
Imagion Biosystems (IBX) has revealed stronger full-year revenue for 2020 as it…

Search Previous Announcements